Market Tracker

04/28 5:16pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

0.5998
Delayed Data
As of Apr 28
 -0.0102 / -1.67%
Today’s Change
0.56
Today|||52-Week Range
2.00
-51.24%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close0.61
Today’s open0.62
Day’s range0.59 - 0.62
Volume47,109
Average volume (3 months)145,901
Market cap$23.6M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-22.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-62.20%
P/E ratioNM
Price/Sales5.82
Price/Book0.51

Competitors

 Today’s
change
Today’s
% change
CLRBCellectar Bioscience...+0.01+0.57%
CYCCCyclacel Pharmaceuti...-0.04-0.74%
ABIOARCA Biopharma Inc-0.05-1.85%
VICLVical Inc+0.05+2.16%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$9.3M
Annual profit (last year)-$25.4M
Net profit margin-273.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts